Skip to main content
. 2020 Oct 23;11(4):973–997. doi: 10.1016/j.jcmgh.2020.10.011

Figure 5.

Figure 5

ABX treatment suppressed ileal FXR activity and altered enterohepatic TBA levels in Atg7Δhepmice. (A) TBA levels in the indicated compartments were measured (n = 4–6). (B) Serum levels of ALT, AST, ALP, and TBA in Atg7Δhep mice after ABX treatment (n = 4–6). (C) Liver weight and gallbladder (Gal) weight were shown as percentage of body weight (n = 4–6). Data are shown as means ± SE. Groups with different lowercase letters had significant differences (P < .05).